Concordance of Actionable Mutations in Liquid Biopsies and Matched Tumor Tissue of Brazilian Nonsmall Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Silva, Marcela de Oliveira [1 ]
dos Reis, Mariana Bisarro [1 ]
Pinto, Icaro Alves [1 ]
Pontes, Natalia Zampieri [1 ]
Chiarantano, Rodrigo Sampaio [1 ]
De Marchi, Pedro [2 ]
Ferreira Da Silva, Flavio Augusto [5 ]
Evangelista, Adriane Feijo [1 ]
Reis, Rui Manuel [1 ,3 ,4 ]
Leal, Leticia Ferro [1 ,6 ]
机构：
[1] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil
[2] Oncoclin, Rio De Janeiro, Brazil
[3] Univ Minho, Life & Hlth Sci Res Inst ICVS, Braga, Portugal
[4] ICVS 3Bs, Govt Associate Laborator, Braga, Portugal
[5] Barretos Canc Hosp, Dept Clin Oncol, Barretos, Brazil
[6] Barretos Sch Med Paulo Prata FACISB, Barretos, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP.20
引用
收藏
页码：S16 / S16
页数：1
相关论文
共 50 条
  • [41] Imaging mutations in non small cell lung cancer (NSCLC)
    Haslop, Anna
    Robins, Edward George
    Goggi, Julian Luke
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S337 - S337
  • [42] Shedding of ctDNA, radiomics assessment of tumor disease volume (TDV), and concordance of mutations (mut) in synchronous liquid and tumor biopsies in metastatic breast cancer (MBC).
    Papakonstantinou, Andri
    Gonzalez-Medina, Alberto
    Matito, Judit
    Ligero, Marta
    Ruiz-Pace, Fiorella
    Sunol, Anna
    Rivero, Joaquin
    Fasani, Roberta
    Cruellas, Mara
    Peg, Vicente
    Borrell, Maria
    Pimentel, Isabel
    Munoz, Santiago Escriva De Romani
    Gelpi, Judith Balmana
    Nuciforo, Paolo
    Dienstmann, Rodrigo
    Saura, Cristina
    Perez-Lopez, Raquel
    Oliveira, Mafalda
    Vivancos, Ana
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [43] Individualized tumor-informed circulating tumor DNA (ctDNA) analysis for postoperative monitoring of nonsmall cell lung cancer (NSCLC) - the MEDAL study
    Chen, Kezhong
    Wang, Chenyang
    Shen, Haifeng
    Li, Xi
    Jin, Yichen
    Wu, Shuailai
    Qiu, Fujun
    Lu, Qiang
    Peng, Di
    Fang, Shuai
    Li, Bing
    Lv, Juan
    Song, Jinlei
    Wang, Yang
    Chuai, Shannon
    Zhang, Zhihong
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Racial Diversity of Actionable Mutations in Non-Small Cell Lung Cancer
    Bollig-Fischer, Aliccia
    Chen, Wei
    Gadgeel, Shirish M.
    Wenzlaff, Angela S.
    Cote, Michele L.
    Schwartz, Ann G.
    Bepler, Gerold
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (02) : 250 - 255
  • [45] Evaluation of stored liquid biopsies for molecular profiling in patients with non-small cell lung cancer (NSCLC).
    Bradbury, Penelope Ann
    Ding, Keyue
    Ellis, Peter Michael
    Seymour, Lesley
    De Kievit, Frank
    Jones, Greg
    Morris, Clive D.
    Green, Emma
    Goss, Glenwood D.
    Tsao, Ming Sound
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung Cancer
    Pellini, Bruna
    Szymanski, Jeffrey
    Chin, Re-, I
    Jones, Paul A.
    Chaudhuri, Aadel A.
    THORACIC SURGERY CLINICS, 2020, 30 (02) : 165 - +
  • [47] Characterization of Actionable BRAFV600E and Co-Mutations in Non-Small Cell Lung Cancer (NSCLC) Patients
    Sanvarinda, P.
    Oranratnachai, S.
    Detarkom, S.
    Iemwimangsa, N.
    Trachu, N.
    Incharoen, P.
    Chantratita, W.
    Reungwetwattana, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1035 - S1035
  • [48] Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer A Systematic Review and Meta-Analysis
    Mao, Chen
    Yuan, Jin-Qiu
    Yang, Zu-Yao
    Fu, Xiao-Hong
    Wu, Xin-Yin
    Tang, Jin-Ling
    MEDICINE, 2015, 94 (21)
  • [49] Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics—A Review
    Maria João Amaral
    Rui Caetano Oliveira
    Paulo Donato
    José Guilherme Tralhão
    Digestive Diseases and Sciences, 2023, 68 : 2811 - 2823
  • [50] Expression of TF (tissue factor) and tissue factor pathway inhibitors (TFPI, TFPI-2) in situ in nonsmall-cell lung cancer (NSCLC)
    Sierko, E
    Ramlau, R
    Zimnoch, L
    Kisiel, W
    Butkiewicz, A
    Wojtukiewicz, MZ
    LUNG CANCER, 2004, 45 : S40 - S40
12345